nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.474	1	CrCrCtD
Aminosalicylic Acid—MPO—Cisplatin—peripheral nervous system neoplasm	0.155	0.507	CbGbCtD
Aminosalicylic Acid—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0535	0.175	CbGbCtD
Aminosalicylic Acid—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0526	0.172	CbGbCtD
Aminosalicylic Acid—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0444	0.145	CbGbCtD
Aminosalicylic Acid—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.000464	0.00296	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00291	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.000452	0.00288	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.000448	0.00286	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000448	0.00285	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000444	0.00283	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000444	0.00283	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000438	0.00279	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.000435	0.00277	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.000432	0.00275	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.000425	0.00271	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000424	0.0027	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000423	0.00269	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00042	0.00268	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00042	0.00268	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00042	0.00267	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00042	0.00267	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00042	0.00267	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000416	0.00265	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000416	0.00265	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000414	0.00264	CcSEcCtD
Aminosalicylic Acid—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000412	0.00262	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000411	0.00262	CcSEcCtD
Aminosalicylic Acid—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000409	0.0026	CcSEcCtD
Aminosalicylic Acid—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000409	0.0026	CcSEcCtD
Aminosalicylic Acid—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000403	0.00257	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000398	0.00254	CcSEcCtD
Aminosalicylic Acid—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.000397	0.00253	CcSEcCtD
Aminosalicylic Acid—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.0025	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.00039	0.00248	CcSEcCtD
Aminosalicylic Acid—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000388	0.00247	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.000385	0.00245	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000384	0.00245	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.000382	0.00243	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000376	0.00239	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000373	0.00238	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000373	0.00237	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000373	0.00237	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000371	0.00236	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00037	0.00236	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00037	0.00236	CcSEcCtD
Aminosalicylic Acid—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.00234	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000368	0.00234	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000365	0.00233	CcSEcCtD
Aminosalicylic Acid—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000355	0.00226	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000353	0.00225	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000352	0.00225	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000351	0.00223	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000351	0.00223	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00035	0.00223	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000343	0.00219	CcSEcCtD
Aminosalicylic Acid—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000343	0.00219	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000343	0.00219	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000342	0.00218	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000342	0.00218	CcSEcCtD
Aminosalicylic Acid—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00217	CcSEcCtD
Aminosalicylic Acid—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00217	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000339	0.00216	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00216	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00216	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00216	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00216	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.00214	CcSEcCtD
Aminosalicylic Acid—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000336	0.00214	CcSEcCtD
Aminosalicylic Acid—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000334	0.00213	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000334	0.00213	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00206	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00203	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000318	0.00203	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.00203	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000316	0.00201	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000316	0.00201	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000316	0.00201	CcSEcCtD
Aminosalicylic Acid—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000313	0.002	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000312	0.00199	CcSEcCtD
Aminosalicylic Acid—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.00197	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000307	0.00196	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00195	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000307	0.00195	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000305	0.00194	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000304	0.00194	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00193	CcSEcCtD
Aminosalicylic Acid—Purpura—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00191	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00191	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000298	0.0019	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00189	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000296	0.00188	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000293	0.00187	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000293	0.00187	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00029	0.00184	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00184	CcSEcCtD
Aminosalicylic Acid—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000287	0.00183	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00183	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000287	0.00182	CcSEcCtD
Aminosalicylic Acid—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000286	0.00182	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00181	CcSEcCtD
Aminosalicylic Acid—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000283	0.00181	CcSEcCtD
Aminosalicylic Acid—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000283	0.00181	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000282	0.0018	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00179	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000278	0.00177	CcSEcCtD
Aminosalicylic Acid—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00177	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000277	0.00176	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000277	0.00176	CcSEcCtD
Aminosalicylic Acid—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000275	0.00175	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00175	CcSEcCtD
Aminosalicylic Acid—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000273	0.00174	CcSEcCtD
Aminosalicylic Acid—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000273	0.00174	CcSEcCtD
Aminosalicylic Acid—Rash—Topotecan—peripheral nervous system neoplasm	0.000272	0.00174	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000272	0.00173	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000272	0.00173	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00173	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00173	CcSEcCtD
Aminosalicylic Acid—Headache—Topotecan—peripheral nervous system neoplasm	0.000271	0.00172	CcSEcCtD
Aminosalicylic Acid—Rash—Tretinoin—peripheral nervous system neoplasm	0.00027	0.00172	CcSEcCtD
Aminosalicylic Acid—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00027	0.00172	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00027	0.00172	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00027	0.00172	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00027	0.00172	CcSEcCtD
Aminosalicylic Acid—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000269	0.00171	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00171	CcSEcCtD
Aminosalicylic Acid—Headache—Tretinoin—peripheral nervous system neoplasm	0.000269	0.00171	CcSEcCtD
Aminosalicylic Acid—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000269	0.00171	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.0017	CcSEcCtD
Aminosalicylic Acid—Rash—Melphalan—peripheral nervous system neoplasm	0.000267	0.0017	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000267	0.0017	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.00169	CcSEcCtD
Aminosalicylic Acid—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000264	0.00168	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000263	0.00167	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.00164	CcSEcCtD
Aminosalicylic Acid—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00164	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00164	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00164	CcSEcCtD
Aminosalicylic Acid—Nausea—Topotecan—peripheral nervous system neoplasm	0.000257	0.00163	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000256	0.00163	CcSEcCtD
Aminosalicylic Acid—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00162	CcSEcCtD
Aminosalicylic Acid—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00162	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000252	0.0016	CcSEcCtD
Aminosalicylic Acid—Nausea—Melphalan—peripheral nervous system neoplasm	0.000251	0.0016	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000248	0.00158	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000247	0.00158	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000247	0.00158	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000246	0.00157	CcSEcCtD
Aminosalicylic Acid—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000242	0.00154	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000241	0.00153	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00024	0.00153	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00152	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00152	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00148	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000231	0.00147	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00144	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000223	0.00142	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.00142	CcSEcCtD
Aminosalicylic Acid—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000221	0.00141	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00022	0.0014	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000219	0.00139	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000219	0.00139	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00139	CcSEcCtD
Aminosalicylic Acid—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00138	CcSEcCtD
Aminosalicylic Acid—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00137	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000214	0.00136	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00133	CcSEcCtD
Aminosalicylic Acid—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.00133	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00132	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Aminosalicylic Acid—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.00132	CcSEcCtD
Aminosalicylic Acid—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.0013	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.0013	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000204	0.0013	CcSEcCtD
Aminosalicylic Acid—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.0013	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00129	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000201	0.00128	CcSEcCtD
Aminosalicylic Acid—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00128	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0002	0.00128	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.0002	0.00128	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00127	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000199	0.00127	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00126	CcSEcCtD
Aminosalicylic Acid—Rash—Vincristine—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000197	0.00126	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00125	CcSEcCtD
Aminosalicylic Acid—Headache—Vincristine—peripheral nervous system neoplasm	0.000196	0.00125	CcSEcCtD
Aminosalicylic Acid—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00123	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00123	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000189	0.00121	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000187	0.00119	CcSEcCtD
Aminosalicylic Acid—Nausea—Vincristine—peripheral nervous system neoplasm	0.000186	0.00118	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00118	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00116	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00116	CcSEcCtD
Aminosalicylic Acid—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000176	0.00112	CcSEcCtD
Aminosalicylic Acid—Rash—Cisplatin—peripheral nervous system neoplasm	0.000175	0.00111	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000174	0.00111	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00111	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000174	0.00111	CcSEcCtD
Aminosalicylic Acid—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000172	0.00109	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00109	CcSEcCtD
Aminosalicylic Acid—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000168	0.00107	CcSEcCtD
Aminosalicylic Acid—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000164	0.00105	CcSEcCtD
Aminosalicylic Acid—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000161	0.00103	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00103	CcSEcCtD
Aminosalicylic Acid—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00103	CcSEcCtD
Aminosalicylic Acid—Rash—Etoposide—peripheral nervous system neoplasm	0.00016	0.00102	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00016	0.00102	CcSEcCtD
Aminosalicylic Acid—Headache—Etoposide—peripheral nervous system neoplasm	0.000159	0.00101	CcSEcCtD
Aminosalicylic Acid—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00101	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.00101	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000993	CcSEcCtD
Aminosalicylic Acid—Nausea—Etoposide—peripheral nervous system neoplasm	0.000151	0.000959	CcSEcCtD
Aminosalicylic Acid—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000949	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000938	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000919	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000888	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000886	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000879	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000868	CcSEcCtD
Aminosalicylic Acid—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000863	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PTPN11—peripheral nervous system neoplasm	0.000134	0.00211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000134	0.00211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	0.000132	0.00208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—AKT1—peripheral nervous system neoplasm	0.00013	0.00206	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—COX2—peripheral nervous system neoplasm	0.00013	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—MYC—peripheral nervous system neoplasm	0.00013	0.00205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.00013	0.00205	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000822	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00082	CcSEcCtD
Aminosalicylic Acid—CHUK—IL-4 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000128	0.00203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—peripheral nervous system neoplasm	0.000128	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—PTPN11—peripheral nervous system neoplasm	0.000128	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—PTPN11—peripheral nervous system neoplasm	0.000128	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—PTPN11—peripheral nervous system neoplasm	0.000128	0.00202	CbGpPWpGaD
Aminosalicylic Acid—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000814	CcSEcCtD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000127	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000127	0.00201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD34—peripheral nervous system neoplasm	0.000127	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PTPN11—peripheral nervous system neoplasm	0.000127	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—RANKL/RANK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000127	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—AKT1—peripheral nervous system neoplasm	0.000127	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—IL-1 signaling pathway—AKT1—peripheral nervous system neoplasm	0.000127	0.002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PTPN11—peripheral nervous system neoplasm	0.000126	0.00198	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000799	CcSEcCtD
Aminosalicylic Acid—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000125	0.00198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PTPN11—peripheral nervous system neoplasm	0.000125	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—peripheral nervous system neoplasm	0.000125	0.00197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000125	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—HRAS—peripheral nervous system neoplasm	0.000124	0.00195	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000787	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000782	CcSEcCtD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000123	0.00193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—HRAS—peripheral nervous system neoplasm	0.000122	0.00193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—HRAS—peripheral nervous system neoplasm	0.000122	0.00193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HGF—peripheral nervous system neoplasm	0.000122	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—ERBB2—peripheral nervous system neoplasm	0.000121	0.00191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PTPN11—peripheral nervous system neoplasm	0.000118	0.00187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	0.000117	0.00184	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00074	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—ERBB2—peripheral nervous system neoplasm	0.000116	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000116	0.00183	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000728	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—NRAS—peripheral nervous system neoplasm	0.000114	0.0018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.000114	0.0018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000114	0.00179	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000723	CcSEcCtD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PTPN11—peripheral nervous system neoplasm	0.000113	0.00179	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000719	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000716	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000716	CcSEcCtD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000112	0.00176	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000112	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.000109	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—AKT1—peripheral nervous system neoplasm	0.000109	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—ERBB2—peripheral nervous system neoplasm	0.000109	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—ERBB2—peripheral nervous system neoplasm	0.000109	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000108	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—AKT1—peripheral nervous system neoplasm	0.000108	0.0017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—AKT1—peripheral nervous system neoplasm	0.000108	0.0017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—ERBB2—peripheral nervous system neoplasm	0.000108	0.0017	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000685	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 signaling—ERBB2—peripheral nervous system neoplasm	0.000107	0.00169	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—peripheral nervous system neoplasm	0.000107	0.00168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—peripheral nervous system neoplasm	0.000106	0.00167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000106	0.00166	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000667	CcSEcCtD
Aminosalicylic Acid—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000666	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000104	0.00164	CbGpPWpGaD
Aminosalicylic Acid—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000662	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000662	CcSEcCtD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000102	0.00161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD55—peripheral nervous system neoplasm	0.000102	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB2—peripheral nervous system neoplasm	0.000101	0.00159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB2—peripheral nervous system neoplasm	0.000101	0.00159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB2—peripheral nervous system neoplasm	0.000101	0.00159	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000101	0.00159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB2—peripheral nervous system neoplasm	0.0001	0.00158	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.95e-05	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB2—peripheral nervous system neoplasm	9.93e-05	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB2—peripheral nervous system neoplasm	9.89e-05	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	9.88e-05	0.00156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	9.8e-05	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GNS—peripheral nervous system neoplasm	9.79e-05	0.00154	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.000619	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000617	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	9.67e-05	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.51e-05	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	9.5e-05	0.0015	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.000599	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB2—peripheral nervous system neoplasm	9.36e-05	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	9.23e-05	0.00145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—HRAS—peripheral nervous system neoplasm	9.11e-05	0.00144	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000576	CcSEcCtD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AKT1—peripheral nervous system neoplasm	9.02e-05	0.00142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—AKT1—peripheral nervous system neoplasm	9.02e-05	0.00142	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9e-05	0.000573	CcSEcCtD
Aminosalicylic Acid—Rash—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000571	CcSEcCtD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	8.96e-05	0.00141	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.00057	CcSEcCtD
Aminosalicylic Acid—Headache—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000567	CcSEcCtD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—PTPN11—peripheral nervous system neoplasm	8.87e-05	0.0014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—AKT1—peripheral nervous system neoplasm	8.85e-05	0.0014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—NRAS—peripheral nervous system neoplasm	8.83e-05	0.00139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNB1—peripheral nervous system neoplasm	8.83e-05	0.00139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	8.72e-05	0.00137	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000554	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	8.69e-05	0.00137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.64e-05	0.00136	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ENO2—peripheral nervous system neoplasm	8.55e-05	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	8.54e-05	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.46e-05	0.00133	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000538	CcSEcCtD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	8.39e-05	0.00132	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000533	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—HRAS—peripheral nervous system neoplasm	8.36e-05	0.00132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	8.3e-05	0.00131	CbGpPWpGaD
Aminosalicylic Acid—Rash—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000528	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000528	CcSEcCtD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	8.27e-05	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	8.26e-05	0.0013	CbGpPWpGaD
Aminosalicylic Acid—Headache—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000525	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	8.22e-05	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—NRAS—peripheral nervous system neoplasm	8.18e-05	0.00129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	8.14e-05	0.00128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	8.06e-05	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	8.04e-05	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—AKT1—peripheral nervous system neoplasm	7.97e-05	0.00126	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000498	CcSEcCtD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	7.78e-05	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	7.72e-05	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	7.72e-05	0.00122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	7.71e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD34—peripheral nervous system neoplasm	7.7e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	7.69e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	7.69e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—NRAS—peripheral nervous system neoplasm	7.69e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	7.62e-05	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	7.56e-05	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	7.55e-05	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	7.52e-05	0.00119	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	7.52e-05	0.00119	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PPP3R1—peripheral nervous system neoplasm	7.42e-05	0.00117	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—BCHE—peripheral nervous system neoplasm	7.22e-05	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NRAS—peripheral nervous system neoplasm	7.12e-05	0.00112	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.03e-05	0.00111	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.89e-05	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	6.89e-05	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.86e-05	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PPP3R1—peripheral nervous system neoplasm	6.85e-05	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	6.81e-05	0.00107	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TH—peripheral nervous system neoplasm	6.79e-05	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	6.75e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.74e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.72e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	6.68e-05	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	6.64e-05	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.57e-05	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NCAM1—peripheral nervous system neoplasm	6.55e-05	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	6.46e-05	0.00102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	6.36e-05	0.001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CASP3—peripheral nervous system neoplasm	6.25e-05	0.000986	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	6.12e-05	0.000965	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	6.07e-05	0.000957	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	6.05e-05	0.000954	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	6.04e-05	0.000952	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	6.03e-05	0.000951	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	6.01e-05	0.000948	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—peripheral nervous system neoplasm	5.98e-05	0.000943	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	5.96e-05	0.00094	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ENO2—peripheral nervous system neoplasm	5.93e-05	0.000935	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	5.9e-05	0.00093	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	5.87e-05	0.000926	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	5.87e-05	0.000925	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	5.86e-05	0.000924	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GNS—peripheral nervous system neoplasm	5.8e-05	0.000914	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	5.7e-05	0.000899	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	5.65e-05	0.00089	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.64e-05	0.00089	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.64e-05	0.000889	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—peripheral nervous system neoplasm	5.63e-05	0.000887	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	5.63e-05	0.000887	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	5.63e-05	0.000887	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	5.61e-05	0.000885	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.58e-05	0.00088	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	5.58e-05	0.000879	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GNAS—peripheral nervous system neoplasm	5.54e-05	0.000874	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.54e-05	0.000873	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	5.53e-05	0.000872	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	5.5e-05	0.000868	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.44e-05	0.000858	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	5.36e-05	0.000845	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	5.33e-05	0.000841	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NRAS—peripheral nervous system neoplasm	5.33e-05	0.00084	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	5.31e-05	0.000837	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—AKT1—peripheral nervous system neoplasm	5.28e-05	0.000833	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NRAS—peripheral nervous system neoplasm	5.24e-05	0.000826	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—peripheral nervous system neoplasm	5.21e-05	0.000821	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	5.21e-05	0.000821	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.2e-05	0.000819	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNB1—peripheral nervous system neoplasm	5.14e-05	0.00081	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.12e-05	0.000806	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	4.98e-05	0.000786	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTPN11—peripheral nervous system neoplasm	4.97e-05	0.000784	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—AKT1—peripheral nervous system neoplasm	4.97e-05	0.000783	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	4.97e-05	0.000783	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	4.97e-05	0.000783	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	4.93e-05	0.000776	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	4.88e-05	0.00077	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	4.86e-05	0.000766	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	4.86e-05	0.000766	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	4.82e-05	0.00076	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.8e-05	0.000756	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SLC2A1—peripheral nervous system neoplasm	4.78e-05	0.000754	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	4.77e-05	0.000753	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.68e-05	0.000737	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	4.66e-05	0.000734	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—AKT1—peripheral nervous system neoplasm	4.6e-05	0.000725	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	4.48e-05	0.000707	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	4.4e-05	0.000694	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	4.06e-05	0.000639	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.99e-05	0.00063	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HGF—peripheral nervous system neoplasm	3.97e-05	0.000626	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB2—peripheral nervous system neoplasm	3.93e-05	0.000619	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—peripheral nervous system neoplasm	3.9e-05	0.000615	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—peripheral nervous system neoplasm	3.83e-05	0.000604	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AKT1—peripheral nervous system neoplasm	3.82e-05	0.000602	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	3.77e-05	0.000595	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	3.71e-05	0.000584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.6e-05	0.000568	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	3.51e-05	0.000554	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—peripheral nervous system neoplasm	3.39e-05	0.000534	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.28e-05	0.000517	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	3.13e-05	0.000494	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.08e-05	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NRAS—peripheral nervous system neoplasm	2.99e-05	0.000471	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.99e-05	0.000471	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	2.94e-05	0.000464	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	2.94e-05	0.000464	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.94e-05	0.000463	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPN11—peripheral nervous system neoplasm	2.9e-05	0.000456	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	2.87e-05	0.000453	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	2.83e-05	0.000446	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.77e-05	0.000437	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.69e-05	0.000425	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTPN11—peripheral nervous system neoplasm	2.67e-05	0.000421	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	2.49e-05	0.000392	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	2.4e-05	0.000379	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.37e-05	0.000374	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.36e-05	0.000372	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	2.34e-05	0.000369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB2—peripheral nervous system neoplasm	2.29e-05	0.000361	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB2—peripheral nervous system neoplasm	2.11e-05	0.000333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	2.1e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	1.91e-05	0.000301	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.87e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.87e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	1.85e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NRAS—peripheral nervous system neoplasm	1.74e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NRAS—peripheral nervous system neoplasm	1.61e-05	0.000253	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	1.58e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—peripheral nervous system neoplasm	1.5e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—peripheral nervous system neoplasm	1.5e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.48e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.34e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—peripheral nervous system neoplasm	1.27e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	1.25e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—peripheral nervous system neoplasm	1.18e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—peripheral nervous system neoplasm	1.12e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.05e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—peripheral nervous system neoplasm	1.04e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	9.52e-06	0.00015	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—peripheral nervous system neoplasm	8.87e-06	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.61e-06	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.23e-06	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.27e-06	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	6.97e-06	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	6.49e-06	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	6.15e-06	9.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	5.15e-06	8.12e-05	CbGpPWpGaD
